Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Past 7 days
Any time
Past hour
Past 24 hours
Past 30 days
Most recent
Best match
4d
Catalent’s Biologics Underperformance and PCH Stability Lead to Hold Rating
Jefferies analyst David Windley maintained a Hold rating on Catalent (CTLT – Research Report) today and set a price target of $63.50.
Hosted on MSN
5d
Catalent's Stock Gains Despite Q1 Earnings Miss, Gross Margin Up
Catalent, Inc. CTLT reported first-quarter fiscal 2025 adjusted loss per share of 13 cents, flat year over year. The figure ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Trending now
US ambassador to UN
Ex-aide urges Biden to quit
Taking charge of US borders
Ex-Rep. Grimm paralyzed
Delaney wins US House seat
Cruise ship rescues 4 people
24 more monkeys found
AZ rejects 'curing' extension
China builds nuclear reactor?
Schweikert wins reelection
TN murder suspect arrested
Shooting suspect arrested
CA forced labor ban rejected
Veteran homelessness drops
COP29 summit begins
US military targets Houthis
Ella Jenkins dies at 100
Quincy Jones laid to rest
Wins 3rd NASCAR Cup title
Tops box office with $16.2M
Israel strikes Gaza, Lebanon
FTX sues Binance
Haiti replaces prime minister
Backs Scott as Senate leader
Reds honor Pete Rose
Ranger dies in wildfire
Concedes to Gabe Evans
WI abortion ban case hearing
UN nuclear head to visit Iran
UKR drones strike Moscow
Judith Jamison dies
FTX sues Scaramucci
Feedback